Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

Similar articles for PubMed (Select 24013575)

1.

Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins.

Hu Y, Cheng X, Li S, Zhou Y, Wang J, Cheng T, Yang M, Xiong D.

Cancer Chemother Pharmacol. 2013 Oct;72(4):789-98. doi: 10.1007/s00280-013-2254-2. Epub 2013 Sep 8.

PMID:
24013575
2.

Sorcin, an important gene associated with multidrug-resistance in human leukemia cells.

Zhou Y, Xu Y, Tan Y, Qi J, Xiao Y, Yang C, Zhu Z, Xiong D.

Leuk Res. 2006 Apr;30(4):469-76. Epub 2005 Oct 6.

PMID:
16213583
3.

[Influence of tetrandrine on SORCIN gene expression in K562/A02 cell line].

Li J, Chen BA, Zhu MS, Gao F, Ding JH, Gao C, Sun YY, Cheng J, Wang J, Zhao G, Song HH, Ma Y, Bao W, Sun XC, Cheng HY, Xu WL, Shen HL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):65-9. Chinese.

PMID:
18315902
4.

Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.

Shi R, Peng H, Yuan X, Zhang X, Zhang Y, Fan D, Liu X, Xiong D.

J Cell Biochem. 2013 Aug;114(8):1890-900. doi: 10.1002/jcb.24533.

PMID:
23494858
5.

Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.

Yamagishi N, Nakao R, Kondo R, Nishitsuji M, Saito Y, Kuga T, Hatayama T, Nakayama Y.

Biochem Biophys Res Commun. 2014 Jun 13;448(4):430-6. doi: 10.1016/j.bbrc.2014.04.125. Epub 2014 May 2.

PMID:
24796664
6.

Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis.

Qi J, Liu N, Zhou Y, Tan Y, Cheng Y, Yang C, Zhu Z, Xiong D.

Biochem Biophys Res Commun. 2006 Oct 13;349(1):303-9. Epub 2006 Aug 15.

PMID:
16934756
7.

[Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells].

Xiao XB, Xie ZX, Qin Q.

Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):422-5. Chinese.

PMID:
17152486
8.

Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo.

Hu Y, Li S, Yang M, Yan C, Fan D, Zhou Y, Zhang Y, Yag├╝e E, Xiong D.

Breast Cancer Res Treat. 2014 Jan;143(2):287-99. doi: 10.1007/s10549-013-2809-2. Epub 2013 Dec 15.

PMID:
24337682
9.

Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.

Chen BA, Shan XY, Chen J, Xia GH, Xu WL, Schmit M.

Chin J Cancer. 2010 Jun;29(6):591-5.

10.

Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.

Shi YQ, Qu XJ, Liao YX, Xie CF, Cheng YN, Li S, Lou HX.

Eur J Pharmacol. 2008 Apr 14;584(1):66-71. doi: 10.1016/j.ejphar.2008.01.039. Epub 2008 Feb 5.

PMID:
18304528
11.

Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.

Cheng Z, Yang N, Liang W, Yan X, Li L, Pan L.

Leuk Lymphoma. 2012 Jul;53(7):1383-9. doi: 10.3109/10428194.2011.650695. Epub 2012 Jan 31.

PMID:
22185283
12.

[Study of mifepristone on reversing multidrug resistance of leukemic cell line K562/A02].

Kong DX, Chen CY, Xu FY, Jia JH.

Zhonghua Xue Ye Xue Za Zhi. 2007 Aug;28(8):555-9. Chinese.

PMID:
18078134
13.

[The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].

Chang HY, Pan KL, Ma FC, Jiao XY, Zhu HF, Liu JH, Huang Y, Cao YH.

Zhonghua Xue Ye Xue Za Zhi. 2006 Apr;27(4):254-8. Chinese.

PMID:
16875558
14.

[Effect of CD44 gene silence on multi-drug resistance reversal and biologic activity in K562/A02 cells].

Liu YP, Liu CF, Ma DX, Lu F, Zhang JJ, Kong HL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Apr;18(2):335-9. Chinese.

PMID:
20416163
15.

[Effects of arsenic trioxide on expressions of vascular endothelial growth factor and P-glycoprotein in multidrug resistant leukemia cell line K562/A02].

Liang H, Zhang Y, Zhang JD, Gu J, Ma L, Wang XL, Shen WG.

Zhong Xi Yi Jie He Xue Bao. 2007 Nov;5(6):647-50. Chinese.

16.

Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.

Fang W, Li Y, Cai Y, Kang K, Yan F, Liu G, Huang W.

J Pharm Pharmacol. 2007 Dec;59(12):1649-55.

PMID:
18053326
17.

PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species.

Peng H, Yuan X, Shi R, Wei X, Ren S, Yan C, Ding Y, Lin Y, Fan D, Yang M, Zhang Y, Xiong D.

Eur J Pharmacol. 2013 Oct 15;718(1-3):459-68. doi: 10.1016/j.ejphar.2013.07.038. Epub 2013 Jul 30.

PMID:
23911883
18.
19.

Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.

Sun LR, Li X, Cheng YN, Yuan HY, Chen MH, Tang W, Ward SG, Qu XJ.

Biomed Pharmacother. 2009 Mar;63(3):202-8. doi: 10.1016/j.biopha.2008.07.090. Epub 2008 Aug 28.

PMID:
18818047
20.

[Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].

Han YQ, Yuan JY, Shi YJ, Zhu Y, Wu SL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Dec;11(6):604-8. Chinese.

PMID:
14706144
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk